Description
In September 2026, Siemens Healthineers announced the launch of Accela, the first radiotherapy solution engineered around NeoArc, combining speed and precision for a broad range of cases while improving the scalability of complex treatments and reducing the time patients spend in radiotherapy treatment. NeoArc dynamic modulated arc therapy (DMAT) is a technique that combines speed and precision, making single breath-hold stereotactic treatment possible and enabling multi-site stereotactic body radiation therapy (SBRT) treatment in as little as 60 seconds.
Accela brings enhanced linac functionality, including a large HyperSight cone-beam CT imaging panel, a newly designed multi-leaf collimator, high-speed gantry rotation at 2.5 RPM, dose rates up to 40 Gy/min, and a new eight-megavolt flattening filter-free energy setting. The planning software’s advanced AI and algorithms allow clinicians to balance optimization of plan quality and delivery speed.
Click HERE to learn more.
G-MedTech –
“Accela is the kind of leap our field doesn’t see often. It’s faster than previous systems, it’s built on a fundamentally modern architecture, and it introduces a generational shift in treatment planning. But what excites me most is its potential to alter the biological response to radiotherapy. That’s not incremental progress; it’s a new chapter.”
— Dee Khuntia MD, chief medical officer at Varian, the Siemens Healthineers cancer-care business